286 related articles for article (PubMed ID: 11160951)
21. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.
Zeng K; Wang X; Xi Z; Yan Y
Clin Neurol Neurosurg; 2010 May; 112(4):291-5. PubMed ID: 20071075
[TBL] [Abstract][Full Text] [Related]
22. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
Posner EB; Mohamed K; Marson AG
Cochrane Database Syst Rev; 2003; (3):CD003032. PubMed ID: 12917940
[TBL] [Abstract][Full Text] [Related]
23. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial.
Marson AG; Al-Kharusi AM; Alwaidh M; Appleton R; Baker GA; Chadwick DW; Cramp C; Cockerell OC; Cooper PN; Doughty J; Eaton B; Gamble C; Goulding PJ; Howell SJ; Hughes A; Jackson M; Jacoby A; Kellett M; Lawson GR; Leach JP; Nicolaides P; Roberts R; Shackley P; Shen J; Smith DF; Smith PE; Smith CT; Vanoli A; Williamson PR;
Lancet; 2007 Mar; 369(9566):1016-26. PubMed ID: 17382828
[TBL] [Abstract][Full Text] [Related]
24. Lamotrigine in treatment of 120 children with epilepsy.
Schlumberger E; Chavez F; Palacios L; Rey E; Pajot N; Dulac O
Epilepsia; 1994; 35(2):359-67. PubMed ID: 8156958
[TBL] [Abstract][Full Text] [Related]
25. Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy.
Fitton A; Goa KL
Drugs; 1995 Oct; 50(4):691-713. PubMed ID: 8536554
[TBL] [Abstract][Full Text] [Related]
26. Evaluate the effects of antiepileptic drugs on reproductive endocrine system in newly diagnosed female epileptic patients receiving either Valproate or Lamotrigine monotherapy: A prospective study.
Sidhu HS; Srinivasa R; Sadhotra A
Epilepsy Res; 2018 Jan; 139():20-27. PubMed ID: 29144993
[TBL] [Abstract][Full Text] [Related]
27. Quality of life and treatment satisfaction in Spanish epilepsy patients on monotherapy with lamotrigine or valproic acid.
Viteri C; Codina M; Cobaleda S; Lahuerta J; Barriga J; Morales MD;
Seizure; 2010 Sep; 19(7):432-8. PubMed ID: 20663691
[TBL] [Abstract][Full Text] [Related]
28. Valproate and lamotrigine in pediatric patients with refractory epilepsy: after the first year.
Thome-Souza S; Valente KD
Pediatr Neurol; 2013 Jun; 48(6):436-42. PubMed ID: 23668867
[TBL] [Abstract][Full Text] [Related]
29. Lamotrigine XR conversion to monotherapy: first study using a historical control group.
French JA; Temkin NR; Shneker BF; Hammer AE; Caldwell PT; Messenheimer JA
Neurotherapeutics; 2012 Jan; 9(1):176-84. PubMed ID: 22139591
[TBL] [Abstract][Full Text] [Related]
30. Adjunctive lamotrigine for partial seizures in patients aged 1 to 24 months.
Piña-Garza JE; Levisohn P; Gucuyener K; Mikati MA; Warnock CR; Conklin HS; Messenheimer J
Neurology; 2008 May; 70(22 Pt 2):2099-108. PubMed ID: 18077797
[TBL] [Abstract][Full Text] [Related]
31. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group.
Brodie MJ; Richens A; Yuen AW
Lancet; 1995 Feb; 345(8948):476-9. PubMed ID: 7710545
[TBL] [Abstract][Full Text] [Related]
32. The relationship between treatment with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalised epilepsies.
Nicolson A; Appleton RE; Chadwick DW; Smith DF
J Neurol Neurosurg Psychiatry; 2004 Jan; 75(1):75-9. PubMed ID: 14707312
[TBL] [Abstract][Full Text] [Related]
33. Effects of Sodium Valproate Combined with Lamotrigine on Quality of Life and Serum Inflammatory Factors in Patients with Poststroke Secondary Epilepsy.
Tao S; Sun J; Hao F; Tang W; Li X; Guo D; Liu X
J Stroke Cerebrovasc Dis; 2020 May; 29(5):104644. PubMed ID: 32081495
[TBL] [Abstract][Full Text] [Related]
34. [Valproic acid versus lamotrigine as a monotherapy for absence epilepsy in children].
Huang TS; Zhu JL; Li B; Hu Y; Chen L; Liao JX
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Aug; 11(8):653-5. PubMed ID: 19695193
[TBL] [Abstract][Full Text] [Related]
35. Effect of divalproex-lamotrigine combination therapy in frontal lobe seizures.
McCabe PH; McNew CD; Michel NC
Arch Neurol; 2001 Aug; 58(8):1264-8. PubMed ID: 11493167
[TBL] [Abstract][Full Text] [Related]
36. Lamotrigine. A review of its use in childhood epilepsy.
Culy CR; Goa KL
Paediatr Drugs; 2000; 2(4):299-330. PubMed ID: 10946418
[TBL] [Abstract][Full Text] [Related]
37. [Effectiveness and tolerance of adjunctive treatment of lamotrigine and conversion to monotherapy in pediatric patients with epilepsy. Preliminary studies].
Toczko A; Mojs E
Neurol Neurochir Pol; 2000; 34 Suppl 1():143-51. PubMed ID: 10768154
[TBL] [Abstract][Full Text] [Related]
38. The use of lamotrigine in juvenile myoclonic epilepsy.
Buchanan N
Seizure; 1996 Jun; 5(2):149-51. PubMed ID: 8795132
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of pregabalin versus lamotrigine in patients with newly diagnosed partial seizures: a phase 3, double-blind, randomised, parallel-group trial.
Kwan P; Brodie MJ; Kälviäinen R; Yurkewicz L; Weaver J; Knapp LE
Lancet Neurol; 2011 Oct; 10(10):881-90. PubMed ID: 21889410
[TBL] [Abstract][Full Text] [Related]
40. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy.
Glauser TA; Cnaan A; Shinnar S; Hirtz DG; Dlugos D; Masur D; Clark PO; Capparelli EV; Adamson PC;
N Engl J Med; 2010 Mar; 362(9):790-9. PubMed ID: 20200383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]